Abstract
Toll-like receptors (TLRs) are important components of innate immune response. The aim of this study was to investigate whether TLR gene cluster (TLR10-TLR1-TLR6) polymorphisms are associated with the etiology of papillary thyroid carcinoma (PTC) and its clinicopathologic characteristics. We recruited 94 PTC patients and 325 control subjects. Genotypes for each SNP were determined by direct sequencing. SNPStats and SPSS 18.0 were used to evaluate odds ratios (ORs), 95 % confidence intervals (CIs), and P values. Multiple logistic regression analyzes of genetic data were performed. The missense SNP rs11466653 was associated with small tumor size (<1 cm) in PTC. The frequency of the rs11466653 T allele was higher in PTC patients with tumors <1 cm in size than in the control group (95.8 vs. 87.2 %; P = 0.021, OR = 0.30, 95 % CI = 0.11–0.83). The T allele of rs11466653 (T/C, Met326Thr) in TLR10 may be a risk factor for the development of tumors in PTC in the Korean population.
Similar content being viewed by others
References
K.W. Jung, S. Park, H.J. Kong, Y.J. Won, J.Y. Lee, H.G. Seo, J.S. Lee, Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res. Treat. 44, 11–24 (2012)
A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115, 3801–3807 (2009)
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun, Cancer statistics, 2009. CA Cancer J. Clin. 59, 225–249 (2009)
M.G. Borrello, L. Alberti, A. Fischer, D. Degl’innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, S. Pilotti, G. Cassinelli, P. Bressan, L. Fugazzola, A. Mantovani, M.A. Pierotti, Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl Acad. Sci. USA 102, 14825–14830 (2005)
A. Pellegrini, N. Guinazu, L. Giordanengo, R.C. Cano, S. Gea, The role of toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan. Future Microbiol. 6, 1521–1533 (2011)
N. Dalgic, D. Tekin, Z. Kayaalti, T. Soylemezoglu, E. Cakir, B. Kilic, B. Kutlubay, M. Sancar, M. Odabasi, Arg753Gln polymorphism of the human toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum. Immunol. 72, 440–445 (2011)
N.S. Palikhe, S.H. Kim, J.H. Kim, P. Losol, Y.M. Ye, H.S. Park, Role of toll-like receptor 3 variants in aspirin-exacerbated respiratory disease. Allergy Asthma Immunol. Res. 3, 123–127 (2011)
M.L. Sales, R. Schreiber, M.C. Ferreira-Sae, M.N. Fernandes, C.S. Piveta, J.A. Cipolli, C.C. Cardoso, J.R. Matos-Souza, B. Geloneze, K.G. Franchini, W. Nadruz Jr, Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women. Am. J. Hypertens. 23, 649–654 (2010)
F.A. Castro, A. Forsti, S. Buch, H. Kalthoff, C. Krauss, M. Bauer, J. Egberts, B. Schniewind, D.C. Broering, S. Schreiber, M. Schmitt, J. Hampe, K. Hemminki, C. Schafmayer, TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur. J. Cancer 47, 1203–1210 (2011)
Z. Vidas, Polymorphisms in toll-like receptor genes—implications for prostate cancer development. Coll. Antropol. 34, 779–783 (2010)
U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck, S. Tancredi, C. Guiet, F. Briere, J. Vlach, S. Lebecque, G. Trinchieri, E.E. Bates, Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 174, 2942–2950 (2005)
T. Chuang, R.J. Ulevitch, Identification of hTLR10: a novel human toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157–161 (2001)
R. Medzhitov, P. Preston-Hurlburt, C.A. Janeway Jr, A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997)
X. Du, A. Poltorak, Y. Wei, B. Beutler, Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11, 362–371 (2000)
O. Takeuchi, T. Kawai, P.F. Muhlradt, M. Morr, J.D. Radolf, A. Zychlinsky, K. Takeda, S. Akira, Discrimination of bacterial lipoproteins by toll-like receptor 6. Int. Immunol. 13, 933–940 (2001)
O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R.L. Modlin, S. Akira, Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10–14 (2002)
A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, C.B. Wilson, L. Schroeder, A. Aderem, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766–13771 (2000)
S. Janssens, R. Beyaert, Role of toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16, 637–646 (2003)
S. Lindstrom, D.J. Hunter, H. Gronberg, P. Stattin, F. Wiklund, J. Xu, S.J. Chanock, R. Hayes, P. Kraft, Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol. Biomarkers Prev. 19, 873–876 (2010)
S.L. Zheng, K. Augustsson-Balter, B. Chang, M. Hedelin, L. Li, H.O. Adami, J. Bensen, G. Li, J.E. Johnasson, A.R. Turner, T.S. Adams, D.A. Meyers, W.B. Isaacs, J. Xu, H. Gronberg, Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 64, 2918–2922 (2004)
J. Sun, F. Wiklund, S.L. Zheng, B. Chang, K. Balter, L. Li, J.E. Johansson, G. Li, H.O. Adami, W. Liu, A. Tolin, A.R. Turner, D.A. Meyers, W.B. Isaacs, J. Xu, H. Gronberg, Sequence variants in toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J. Natl. Cancer Inst. 97, 525–532 (2005)
M. Canadas Garre, M. Lopez de la Torre Casares, P. Becerra Massare, M.A. Lopez Nevot, J. Villar Del Moral, N. Munoz Perez, R. Vilchez Joya, R. Montes Ramirez, J.M. Llamas Elvira, BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma. Endocrinol. Nutr. 58, 175–184 (2011)
R. Iuliano, D. Palmieri, H. He, A. Iervolino, E. Borbone, P. Pallante, A. Cianflone, R. Nagy, H. Alder, G.A. Calin, F. Trapasso, C. Giordano, C.M. Croce, A. de la Chapelle, A. Fusco, Role of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr. Relat. Cancer 17, 1001–1006 (2010)
A. Salajegheh, R.A. Smith, K. Kasem, V. Gopalan, M.R. Nassiri, R. William, A.K. Lam, Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur. J. Surg. Oncol. 37, 93–99 (2011)
N. Kurtulmus, M. Duren, U. Ince, M. Cengiz Yakicier, O. Peker, O. Aydin, E. Altiok, S. Giray, H. Azizlerli, BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine 42, 404–410 (2012)
M.P. Purdue et al., A pooled investigation of toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 30, 275–281 (2009)
V.L. Stevens, A.W. Hsing, J.T. Talbot, S.L. Zheng, J. Sun, J. Chen, M.J. Thun, J. Xu, E.E. Calle, C. Rodriguez, Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int. J. Cancer 123, 2644–2650 (2008)
Conflicts of interest
There are no potential conflicts of interest relevant to this study to report.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Joo-Ho Chung and Young Gyu Eun contributed equally to this study.
Rights and permissions
About this article
Cite this article
Kim, S.K., Park, H.J., Hong, I.K. et al. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population. Endocrine 43, 161–169 (2013). https://doi.org/10.1007/s12020-012-9783-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9783-z